Detalhe da pesquisa
1.
An azabisphosphonate-capped poly(phosphorhydrazone) dendrimer for the treatment of endotoxin-induced uveitis.
Molecules
; 18(8): 9305-16, 2013 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23921793
2.
Ocular distribution, spectrum of activity, and in vivo viral neutralization of a fully humanized anti-herpes simplex virus IgG Fab fragment following topical application.
Antimicrob Agents Chemother
; 56(3): 1390-402, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203590
3.
Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial.
Am J Ophthalmol
; 174: 76-84, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27810317
4.
Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study.
J Ocul Pharmacol Ther
; 31(2): 93-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25347151
5.
Subconjunctival injection of XG-102, a c-Jun N-terminal kinase inhibitor peptide, in the treatment of endotoxin-induced uveitis in rats.
J Ocul Pharmacol Ther
; 31(1): 17-24, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25313830
6.
XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study.
Pharmacol Res Perspect
; 2(1): e00020, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25505576
7.
A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis.
Invest Ophthalmol Vis Sci
; 51(9): 4683-93, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20393119